Literature DB >> 21398283

Focal macular electroretinogram in macular edema secondary to central retinal vein occlusion.

Ken Ogino1, Akitaka Tsujikawa, Hajime Nakamura, Kazuaki Miyamoto, Tomoaki Murakami, Yuki Muraoka, Yumiko Kurashige, Nagahisa Yoshimura.   

Abstract

PURPOSE: To evaluate the usefulness of focal macular electroretinography (fmERG) for evaluation of macular function in eyes with central retinal vein occlusion (CRVO).
METHODS: fmERG recordings were made prospectively in 24 patients with unilateral CRVO. The amplitudes and latencies of the a-wave, b-wave, and photopic negative response (PhNR) were compared with other biological parameters, including visual acuity (VA), retinal sensitivity measured with a microperimeter, and optical coherence tomography.
RESULTS: In eyes affected by CRVO, amplitudes of the a-wave, b-wave, and PhNR were reduced significantly, and latencies were prolonged significantly compared with those of healthy fellow eyes (P < 0.001). Relative amplitudes (affected eye/fellow eye) of each wave showed a cross correlation with VA. Furthermore, both relative amplitudes and latencies of each wave tended to correlate with retinal sensitivity within the macular area. Central foveal thickness showed a correlation with both relative amplitude and relative latency. Among all parameters, relative amplitude of the PhNR correlated most strongly with central foveal thickness (r = -0.598, P = 0.0042). In addition, sensory retinal thickness showed a correlation with relative latencies, and height of the retinal detachment (when present) showed a correlation with relative amplitudes. In ischemic CRVO, relative amplitudes were reduced more severely than were those in nonischemic CRVO.
CONCLUSIONS: In eyes with CRVO, amplitudes and latencies of the fmERG correlated with other biological parameters. Based on the present study, fmERG appears to be useful for the examination of the macular edema that accompanies CRVO.

Entities:  

Mesh:

Year:  2011        PMID: 21398283     DOI: 10.1167/iovs.10-7142

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Efficacy of an Anti-Semaphorin 3A Neutralizing Antibody in a Male Experimental Retinal Vein Occlusion Mouse Model.

Authors:  Shinsuke Nakamura; Anri Nishinaka; Yae Hidaka; Masamitsu Shimazawa; Leo Thomas; Remko A Bakker; Hideaki Hara
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-07-08       Impact factor: 4.925

Review 2.  Potential Prognostic Indicators for Patients With Retinal Vein Occlusion.

Authors:  Shan Yin; Yanyan Cui; Wanzhen Jiao; Bojun Zhao
Journal:  Front Med (Lausanne)       Date:  2022-05-25

3.  Multimodal evaluation of macular function in age-related macular degeneration.

Authors:  Ken Ogino; Akitaka Tsujikawa; Kenji Yamashiro; Sotaro Ooto; Akio Oishi; Isao Nakata; Masahiro Miyake; Ayako Takahashi; Abdallah A Ellabban; Nagahisa Yoshimura
Journal:  Jpn J Ophthalmol       Date:  2013-12-12       Impact factor: 2.447

4.  Visual prognostic value of photopic negative response and optical coherence tomography in central retinal vein occlusion after anti-VEGF treatment.

Authors:  Chan Hee Moon; Sang Il Ahn; Young-Hoon Ohn; Hyung Woo Kwak; Tae Kwann Park
Journal:  Doc Ophthalmol       Date:  2013-03-15       Impact factor: 2.379

5.  Central macular thickness in patients with type 2 diabetes mellitus without clinical retinopathy.

Authors:  Mehmet Demir; Ersin Oba; Burcu Dirim; Erhan Ozdal; Efe Can
Journal:  BMC Ophthalmol       Date:  2013-04-09       Impact factor: 2.209

6.  Cental Macular Thickness in Patients with Type 2 Diabetes Mellitus without Clinical Retinopathy.

Authors:  Mehmet Demir; Burcu Dirim; Zeynep Acar; Murat Yılmaz; Yekta Sendul
Journal:  J Ophthalmol       Date:  2013-04-03       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.